Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Half Year Results, Strong Performance Improvements

BLIS Technologies Ltd Reports Half Year Results and Strong Improvements in Performance.

Dunedin, NZ - Nov 23 – (MediaCom) BLIS Technologies Ltd (NZX: BLT)

BLIS Technologies Ltd (NZX: BLT), developers and manufacturers of advanced oral probiotics , announced yesterday, significant improvements in financial performance with a reduction of their operating deficit and a 20% increase in sales for the half year period ended 30th September, 2006.

“Improvements in operational efficiencies, combined with increases in domestic and international sales, has lead to nearly halving the operating deficit for the six months ending 30th Sept.” according to CEO, Dr Barry Richardson. “We are very pleased with these improvements and believe that this will provide us the momentum we need to future improvements in our fundamentals”

BLIS Technologies Ltd has undertaken significant re-organization in the last few months. The introduction of a new Chief Executive Officer, Dr Barry Richardson, with a proven record of commercial development of nutritional and specialty ingredients, has allowed former BLIS CEO, Dr Chris Chilcott to concentrate on product support as the company focuses on international market development and achieving profitability.

Dr Richardson indicated that the launch of the branded product, “TravelGuard” in pharmacies throughout New Zealand was evidence that the company is moving forward with its plan to rollout new and innovative products and product applications. BLIS Technologies Ltd has also announced it has been granted two additional patents during the last six months. “Both of these patents are of strategic importance to the company” said Dr Richardson “one patent protects us in a key market and the other means that we can be more aggressive in the development of new products for the prevention of tooth decay”

In addition to its work on expanding sales in New Zealand and Australia, BLIS Technologies Ltd is also focused on international markets. The company is maintaining its sales efforts in its key markets of Spain, Germany, Japan, Taiwan, and the United States. Regulatory approvals have cleared the way for a mid-2007 launch in Spain. Germany has the Fresh Breath Kit in a test market phase and the company expects product launches in Japan and the United States during 2007.

BLIS Technologies Ltd is in continuing discussions with interested parties regarding significant investment in the company.

ENDS

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Media Mega Merger: StuffMe Hearing Argues Over Moveable Feast

New Zealand's two largest news publishers are appealing against the Commerce Commission's rejection of the proposal to merge their operations. More>>

Elsewhere:


Approval: Northern Corridor Decision Released

The approval gives the green light to construction of the last link of Auckland’s Western Ring Route, providing an alternative route from South Auckland to the North Shore. More>>

ALSO:


Crown Accounts: $4.1 Billion Surplus

The New Zealand Government has achieved its third fiscal surplus in a row with the Crown accounts for the year ended 30 June 2017 showing an OBEGAL surplus of $4.1 billion, $2.2 billion stronger than last year, Finance Minister Steven Joyce says. More>>

ALSO:

Mycoplasma Bovis: One New Property Tests Positive

The newly identified property... was already under a Restricted Place notice under the Biosecurity Act. More>>

Accounting Scandal: Suspension Of Fuji Xerox From All-Of-Government Contract

General Manager of New Zealand Government Procurement John Ivil says, “FXNZ has been formally suspended from the Print Technology and Associated Services (PTAS) contract and terminated from the Office Supplies contract.” More>>